Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Inks $300M Credit Agreement

NEW YORK (GenomeWeb) – Myriad Genetics reported in an 8-K filing with the US Securities and Exchange Commission today that it has entered into a credit agreement for a principal amount of $300 million.

The revolving credit facility includes $10 million sublimits for swingline loans and letters of credit. Myriad borrowed $205 million in revolving loans from the credit facility, which matures on December 23, 2021.

According to the SEC document, the proceeds were used to refinance Myriad's obligations under a loan agreement inked on August 31, and pay related fees. The proceeds were also used as working capital and for "general corporate purposes."

JP Morgan Chase is serving as administrative and collateral agent; Wells Fargo Bank, National Association, is serving as syndication agent; and U.S. Bank, PNC Bank, Fifth Third Bank, Zions First National Bank, and Silicon Valley Bank, are co-documentation agents. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.